Severe enduring anorexia nervosa (SE-AN) treatment options and their effectiveness: a review of literature.
Anorexia nervosa
Chronicity
Eating disorders
Severe-enduring
Treatments
Journal
Journal of eating disorders
ISSN: 2050-2974
Titre abrégé: J Eat Disord
Pays: England
ID NLM: 101610672
Informations de publication
Date de publication:
23 Apr 2024
23 Apr 2024
Historique:
received:
20
10
2023
accepted:
16
04
2024
medline:
24
4
2024
pubmed:
24
4
2024
entrez:
23
4
2024
Statut:
epublish
Résumé
For nearly 20% of patients diagnosed with Anorexia Nervosa (AN), the eating disorder (ED) is prolonged and becomes long-lasting. It has been reported that patients diagnosed with Severe Enduring Anorexia Nervosa (SE-AN) have worse ED symptoms, higher rates of lifetime hospitalization, and lower psychosocial well-being compared to patients with shorter disease duration. This review aims to describe the treatments proposed to date and their effectiveness on SE-AN-related outcomes. We conducted a PubMed search for studies addressing the issue of treatment approach to SE-AN adults, that were published between 2003 and 2023, peer-reviewed, written in the English language, and available in full-text. Next, we inductively created relevant macro-themes by synthesizing the data from the included articles. Of 251 PubMed studies, 25 articles were considered for data extraction, all published between 2003 and 2022. We identified three macro-themes. The first macro-theme, "Psychotherapy", mostly takes into consideration treatment effectiveness of cognitive behavioral therapy (CBT). Various reports determined its greater effectiveness compared to Specialist Supportive Clinical Management (SSCM), and one study proved that outpatient CBT is a valid alternative to hospitalization. The second one involves "Pharmacological Treatments". Research on dronabinol, a synthetic orexigenic cannabinoid, antipsychotics (in particular, olanzapine and haloperidol), and ketamine showed some mixed results regarding the often-complementary areas of weight gain and improvement in ED-related symptoms. Regarding the third macro-theme, "Brain Stimulation Therapies," such as Repetitive Transcranial Magnetic Stimulation (rTMS) and Deep Brain Stimulation (DBS), we found promising results in improving ED-related psychological traits (such as mood and anxiety), affective regulation, and quality of life. However, we have observed divergent results regarding outcome measures such as BMI and weight gain. SE-AN patients are predicted to encounter both medical complications and psychological distress of increasing severity that will inevitably affect their quality of life; to our knowledge, research evidence on treatment options for SE-AN remains limited, and the methodological quality of studies is generally low. These findings denote the need to focus future research efforts on effective treatment strategies specific to long-lasting EDs. For nearly 20% of patients diagnosed with Anorexia Nervosa, the eating disorder is prolonged and becomes long-lasting. Those patients have worse ED symptoms, higher rates of lifetime hospitalization, and lower psychosocial well-being compared to patients with shorter disease duration. This review aims to describe the treatments proposed to date and their effectiveness on severe enduring anorexia nervosa related outcomes. The data obtained show how the intervention techniques primarily used in these patients are psychotherapy (in particular, cognitive behavioral therapy and Specialist Supportive Clinical Management), pharmacological treatments, and Brain Stimulation Therapies (such as Repetitive Transcranial Magnetic Stimulation and Deep Brain Stimulation). To our knowledge, research evidence on treatment options for SE-AN remains limited and these findings denote the need to focus future research efforts on effective treatment strategies specific to long-lasting eating disorders.
Autres résumés
Type: plain-language-summary
(eng)
For nearly 20% of patients diagnosed with Anorexia Nervosa, the eating disorder is prolonged and becomes long-lasting. Those patients have worse ED symptoms, higher rates of lifetime hospitalization, and lower psychosocial well-being compared to patients with shorter disease duration. This review aims to describe the treatments proposed to date and their effectiveness on severe enduring anorexia nervosa related outcomes. The data obtained show how the intervention techniques primarily used in these patients are psychotherapy (in particular, cognitive behavioral therapy and Specialist Supportive Clinical Management), pharmacological treatments, and Brain Stimulation Therapies (such as Repetitive Transcranial Magnetic Stimulation and Deep Brain Stimulation). To our knowledge, research evidence on treatment options for SE-AN remains limited and these findings denote the need to focus future research efforts on effective treatment strategies specific to long-lasting eating disorders.
Identifiants
pubmed: 38654374
doi: 10.1186/s40337-024-01006-y
pii: 10.1186/s40337-024-01006-y
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
48Informations de copyright
© 2024. The Author(s).
Références
Dobrescu SR, Dinkler L, Gillberg C, Råstam M, Gillberg C, Wentz E. Anorexia nervosa: 30-year outcome. Br J Psychiatry J Ment Sci. 2020;216(2):97–104.
doi: 10.1192/bjp.2019.113
Fichter MM, Quadflieg N, Crosby RD, Koch S. Long-term outcome of anorexia nervosa: results from a large clinical longitudinal study. Int J Eat Disord. 2017;50(9):1018–30.
pubmed: 28644530
doi: 10.1002/eat.22736
Nagy H, Paul T, Jain E, Loh H, Kazmi SH, Dua R, et al. A clinical overview of anorexia nervosa and overcoming treatment resistance. Avicenna J Med. 2023;13(1):3–14.
pubmed: 36969350
doi: 10.1055/s-0042-1758859
Steinhausen HC. Outcome of eating disorders. Child Adolesc Psychiatr Clin N Am. 2009;18(1):225–42.
pubmed: 19014869
doi: 10.1016/j.chc.2008.07.013
Mehler PS, Brown C. Anorexia nervosa—medical complications. J Eat Disord. 2015;3:11.
pubmed: 25834735
pmcid: 4381361
doi: 10.1186/s40337-015-0040-8
Cost J, Krantz MJ, Mehler PS. Medical complications of anorexia nervosa. Cleve Clin J Med. 2020;87(6):361–6.
pubmed: 32487556
doi: 10.3949/ccjm.87a.19084
Young S, Touyz S, Meyer C, Arcelus J, Rhodes P, Madden S, et al. Relationships between compulsive exercise, quality of life, psychological distress and motivation to change in adults with anorexia nervosa. J Eat Disord. 2018;6:2.
pubmed: 29441204
pmcid: 5799909
doi: 10.1186/s40337-018-0188-0
Jenkins ZM, Chait LM, Cistullo L, Castle DJ. A comparison of eating disorder symptomatology, psychological distress and psychosocial function between early, typical and later onset anorexia nervosa. J Eat Disord. 2020;8(1):56.
pubmed: 33292580
pmcid: 7640671
doi: 10.1186/s40337-020-00337-w
Calugi S, El Ghoch M, Dalle GR. Intensive enhanced cognitive behavioural therapy for severe and enduring anorexia nervosa: a longitudinal outcome study. Behav Res Ther. 2017;89:41–8.
pubmed: 27863331
doi: 10.1016/j.brat.2016.11.006
Broomfield C, Stedal K, Touyz S, Rhodes P. Labeling and defining severe and enduring anorexia nervosa: a systematic review and critical analysis. Int J Eat Disord. 2017;50(6):611–23.
pubmed: 28444828
doi: 10.1002/eat.22715
Hay P, Touyz S. Treatment of patients with severe and enduring eating disorders. Curr Opin Psychiatry. 2015;28(6):473–7.
pubmed: 26382154
doi: 10.1097/YCO.0000000000000191
Herpertz-Dahlmann B. Serious and enduring anorexia nervosa from a developmental point of view: How to detect potential risks at an early stage and prevent chronic illness? Int J Eat Disord. 2020;53(8):1313–4.
pubmed: 32538483
doi: 10.1002/eat.23329
Speciani M, Barak Y, Damanhuri H, De Ronchi D, Panariello F, Atti AR. A perspective on chronic and long-lasting anorexia nervosa. Front Psychiatry. 2021. https://doi.org/10.3389/fpsyt.2021.756669 .
doi: 10.3389/fpsyt.2021.756669
pubmed: 34777061
pmcid: 8585925
Ambwani S, Cardi V, Albano G, Cao L, Crosby RD, Macdonald P, et al. A multicenter audit of outpatient care for adult anorexia nervosa: Symptom trajectory, service use, and evidence in support of “early stage” versus “severe and enduring” classification. Int J Eat Disord. 2020;53(8):1337–48.
pubmed: 32064663
doi: 10.1002/eat.23246
Davidsen AH, Hoyt WT, Poulsen S, Waaddegaard M, Lau M. Eating disorder severity and functional impairment: moderating effects of illness duration in a clinical sample. Eat Weight Disord EWD. 2017;22(3):499–507.
pubmed: 27659175
doi: 10.1007/s40519-016-0319-z
de Vos JA, Radstaak M, Bohlmeijer ET, Westerhof GJ. Having an eating disorder and still being able to flourish? Examination of pathological symptoms and well-being as two continua of mental health in a clinical sample. Front Psychol. 2018;9:2145.
pubmed: 30498463
pmcid: 6249270
doi: 10.3389/fpsyg.2018.02145
Flynn M, Austin A, Lang K, Allen K, Bassi R, Brady G, et al. Assessing the impact of first episode rapid early intervention for eating disorders on duration of untreated eating disorder: a multi-centre quasi-experimental study. Eur Eat Disord Rev J Eat Disord Assoc. 2021;29(3):458–71.
doi: 10.1002/erv.2797
Marcolini F, Ravaglia A, Tempia Valenta S, Bosco G, Marconi G, Sanna F, et al. Severe-enduring anorexia nervosa (SE-AN): a case series. J Eat Disord. 2023;11(1):208.
pubmed: 37993899
pmcid: 10664281
doi: 10.1186/s40337-023-00925-6
Hay P, Touyz S. Classification challenges in the field of eating disorders: Can severe and enduring anorexia nervosa be better defined? J Eat Disord. 2018;6:41.
pubmed: 30555695
pmcid: 6287358
doi: 10.1186/s40337-018-0229-8
Treasure J, Stein D, Maguire S. Has the time come for a staging model to map the course of eating disorders from high risk to severe enduring illness? An examination of the evidence. Early Interv Psychiatry. 2015;9(3):173–84.
pubmed: 25263388
doi: 10.1111/eip.12170
Treasure J, Cardi V, Leppanen J, Turton R. New treatment approaches for severe and enduring eating disorders. Physiol Behav. 2015;152(Pt B):456–65.
pubmed: 26057573
doi: 10.1016/j.physbeh.2015.06.007
Wonderlich S, Mitchell JE, Crosby RD, Myers TC, Kadlec K, Lahaise K, et al. Minimizing and treating chronicity in the eating disorders: a clinical overview. Int J Eat Disord. 2012;45(4):467–75.
pubmed: 22271525
doi: 10.1002/eat.20978
Treasure J, Duarte TA, Schmidt U. Eating disorders. Lancet Lond Engl. 2020;395(10227):899–911.
doi: 10.1016/S0140-6736(20)30059-3
Fonville L, Giampietro V, Williams SCR, Simmons A, Tchanturia K. Alterations in brain structure in adults with anorexia nervosa and the impact of illness duration. Psychol Med. 2014;44(9):1965–75.
pubmed: 24074139
doi: 10.1017/S0033291713002389
Crow SJ. Pharmacologic treatment of eating disorders. Psychiatr Clin North Am. 2019;42(2):253–62.
pubmed: 31046927
doi: 10.1016/j.psc.2019.01.007
Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, et al. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry. 2019;176(6):449–56.
pubmed: 30654643
pmcid: 7015155
doi: 10.1176/appi.ajp.2018.18101125
Han R, Bian Q, Chen H. Effectiveness of olanzapine in the treatment of anorexia nervosa: a systematic review and meta-analysis. Brain Behav. 2022;12(2): e2498.
pubmed: 35020271
pmcid: 8865148
doi: 10.1002/brb3.2498
Andries A, Frystyk J, Flyvbjerg A, Støving RK. Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: results from a randomised, controlled trial. Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc. 2015;25(5):247–52.
doi: 10.1016/j.ghir.2015.07.006
Himmerich H, Kan C, Au K, Treasure J. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacol Ther. 2021;217: 107667.
pubmed: 32858054
doi: 10.1016/j.pharmthera.2020.107667
Hoch E, Niemann D, von Keller R, Schneider M, Friemel CM, Preuss UW, et al. How effective and safe is medical cannabis as a treatment of mental disorders? a systematic review. Eur Arch Psychiatry Clin Neurosci. 2019;269(1):87–105.
pubmed: 30706168
pmcid: 6595000
doi: 10.1007/s00406-019-00984-4
Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):1000097.
doi: 10.1371/journal.pmed.1000097
Touyz S, Le Grange D, Lacey H, Hay P, Smith R, Maguire S, et al. Treating severe and enduring anorexia nervosa: a randomized controlled trial. Psychol Med. 2013;43(12):2501–11.
pubmed: 23642330
doi: 10.1017/S0033291713000949
Dalton B, Bartholdy S, McClelland J, Kekic M, Rennalls SJ, Werthmann J, et al. Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: the TIARA study. BMJ Open. 2018;8(7): e021531.
pubmed: 30012789
pmcid: 6082449
doi: 10.1136/bmjopen-2018-021531
Dalton B, Foerde K, Bartholdy S, McClelland J, Kekic M, Grycuk L, et al. The effect of repetitive transcranial magnetic stimulation on food choice-related self-control in patients with severe, enduring anorexia nervosa. Int J Eat Disord. 2020;53(8):1326–36.
pubmed: 32309882
doi: 10.1002/eat.23267
Villalba Martínez G, Justicia A, Salgado P, Ginés JM, Guardiola R, Cedrón C, et al. A randomized trial of deep brain stimulation to the subcallosal cingulate and nucleus accumbens in patients with treatment-refractory, chronic, and severe anorexia nervosa: initial results at 6 months of follow up. J Clin Med. 2020;9(6):1946.
pubmed: 32580399
pmcid: 7357090
doi: 10.3390/jcm9061946
Abd Elbaky GB, Hay PJ, le Grange D, Lacey H, Crosby RD, Touyz S. Pre-treatment predictors of attrition in a randomised controlled trial of psychological therapy for severe and enduring anorexia nervosa. BMC Psychiatry. 2014;14(1):69.
pubmed: 24606873
pmcid: 3995934
doi: 10.1186/1471-244X-14-69
Dalle Grave R, Calugi S, Conti M, Doll H, Fairburn CG. Inpatient cognitive behaviour therapy for anorexia nervosa: a randomized controlled trial. Psychother Psychosom. 2013;82(6):390–8.
pubmed: 24060628
pmcid: 3884188
doi: 10.1159/000350058
Bartholdy S, McClelland J, Kekic M, O’Daly OG, Campbell IC, Werthmann J, et al. Clinical outcomes and neural correlates of 20 sessions of repetitive transcranial magnetic stimulation in severe and enduring anorexia nervosa (the TIARA study): study protocol for a randomised controlled feasibility trial. Trials. 2015;16(1):548.
pubmed: 26634828
pmcid: 4668644
doi: 10.1186/s13063-015-1069-3
Israely M, Ram A, Brandeis R, Alter Z, Avraham Y, Berry EM. A double blind, randomized cross-over trial of tyrosine treatment on cognitive function and psychological parameters in severe hospitalized anorexia nervosa patients. Isr J Psychiatry. 2017;54(3):52–8.
pubmed: 29735813
Le Grange D, Fitzsimmons-Craft EE, Crosby RD, Hay P, Lacey H, Bamford B, et al. Predictors and moderators of outcome for severe and enduring anorexia nervosa. Behav Res Ther. 2014;56:91–8.
pubmed: 24727364
doi: 10.1016/j.brat.2014.03.006
Dalton B, Maloney E, Rennalls SJ, Bartholdy S, Kekic M, McClelland J, et al. A pilot study exploring the effect of repetitive transcranial magnetic stimulation (rTMS) treatment on cerebral blood flow and its relation to clinical outcomes in severe enduring anorexia nervosa. J Eat Disord. 2021;9(1):84.
pubmed: 34243816
pmcid: 8268186
doi: 10.1186/s40337-021-00420-w
Van den Eynde F, Guillaume S, Broadbent H, Campbell IC, Schmidt U. Repetitive transcranial magnetic stimulation in anorexia nervosa: a pilot study. Eur Psychiatry J Assoc Eur Psychiatr. 2013;28(2):98–101.
doi: 10.1016/j.eurpsy.2011.06.002
Calabrese L, Scolnick B, Zupec-Kania B, Beckwith C, Costello K, Frank GKW. Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study. Eat Weight Disord EWD. 2022;27(8):3751–7.
pubmed: 35997954
doi: 10.1007/s40519-022-01455-x
Schwartz T, Trunko ME, Feifel D, Lopez E, Peterson D, Frank GKW, et al. A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression. Clin Case Rep. 2021;9(5): e03869.
pubmed: 34026123
pmcid: 8117825
doi: 10.1002/ccr3.3869
Park LE. Appearance-based rejection sensitivity: implications for mental and physical health, affect, and motivation. Pers Soc Psychol Bull. 2007;33(4):490–504.
pubmed: 17363761
doi: 10.1177/0146167206296301
Frostad S, Calugi S, Engen CBN, Dalle GR. Enhanced cognitive behaviour therapy (CBT-E) for severe and extreme anorexia nervosa in an outpatient eating disorder unit at a public hospital: a quality-assessment study. J Eat Disord. 2021;9(1):143.
pubmed: 34727976
pmcid: 8561966
doi: 10.1186/s40337-021-00499-1
Dalton B, Austin A, Ching BCF, Potterton R, McClelland J, Bartholdy S, et al. “My dad was like ‘it’s your brain, what are you doing?’”: Participant experiences of repetitive transcranial magnetic stimulation treatment in severe enduring anorexia nervosa. Eur Eat Disord Rev J Eat Disord Assoc. 2022;30(3):237–49.
doi: 10.1002/erv.2890
Lipsman N, Lam E, Volpini M, Sutandar K, Twose R, Giacobbe P, et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry. 2017;4(4):285–94.
pubmed: 28238701
doi: 10.1016/S2215-0366(17)30076-7
Cassano GB, Miniati M, Pini S, Rotondo A, Banti S, Borri C, et al. Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report. Int J Eat Disord. 2003;33(2):172–7.
pubmed: 12616583
doi: 10.1002/eat.10130
McClelland J, Kekic M, Campbell IC, Schmidt U. Repetitive transcranial magnetic stimulation (rTMS) treatment in enduring anorexia nervosa: a case series. Eur Eat Disord Rev J Eat Disord Assoc. 2016;24(2):157–63.
doi: 10.1002/erv.2414
Mauri M, Miniati M, Mariani MG, Ciberti A, Dell’Osso L. Haloperidol for severe anorexia nervosa restricting type with delusional body image disturbance: a nine-case chart review. Eat Weight Disord EWD. 2013;18(3):329–32.
pubmed: 23907761
doi: 10.1007/s40519-013-0052-9
Fernandes Arroteia I, Husch A, Baniasadi M, Hertel F. Impressive weight gain after deep brain stimulation of nucleus accumbens in treatment-resistant bulimic anorexia nervosa. BMJ Case Rep. 2020;13(11): e239316.
pubmed: 33257397
pmcid: 7705521
doi: 10.1136/bcr-2020-239316
Guerrero Alzola F, Casas Rivero J, Martínez-Álvarez R. Stereotactic surgery on a female patient with severe chronic anorexia nervosa: 10-year follow-up. Eat Weight Disord EWD. 2020;25(6):1827–31.
pubmed: 31595460
doi: 10.1007/s40519-019-00787-5
McIntosh VVW, Jordan J, Luty SE, Carter FA, McKenzie JM, Bulik CM, et al. Specialist supportive clinical management for anorexia nervosa. Int J Eat Disord. 2006;39(8):625–32.
pubmed: 16937382
doi: 10.1002/eat.20297
Mond JM, Hay PJ, Rodgers B, Owen C, Beumont PJV. Validity of the eating disorder examination questionnaire (EDE-Q) in screening for eating disorders in community samples. Behav Res Ther. 2004;42(5):551–67.
pubmed: 15033501
doi: 10.1016/S0005-7967(03)00161-X
Andries A, Frystyk J, Flyvbjerg A, Støving RK. Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial. Int J Eat Disord. 2014;47(1):18–23.
pubmed: 24105610
doi: 10.1002/eat.22173
Graap H, Erim Y, Paslakis G. The effect of dronabinol in a male patient with anorexia nervosa suffering from severe acute urge to be physically active. Int J Eat Disord. 2018;51(2):180–3.
pubmed: 29197104
doi: 10.1002/eat.22804
Ehrlich S, Franke L, Schneider N, Salbach-Andrae H, Schott R, Craciun EM, et al. Aromatic amino acids in weight-recovered females with anorexia nervosa. Int J Eat Disord. 2009;42(2):166–72.
pubmed: 18803171
doi: 10.1002/eat.20575
Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry. 2006;19(4):389–94.
pubmed: 16721169
doi: 10.1097/01.yco.0000228759.95237.78
Hart M, Sibbritt D, Williams LT, Nunn KP, Wilcken B. Progressing our understanding of the impacts of nutrition on the brain and behaviour in anorexia nervosa: a tyrosine case study example. J Eat Disord. 2021;9(1):86.
pubmed: 34256868
pmcid: 8278653
doi: 10.1186/s40337-021-00439-z
Hase A, Jung SE, Rot AH, M. Behavioral and cognitive effects of tyrosine intake in healthy human adults. Pharmacol Biochem Behav. 2015;133:1–6.
pubmed: 25797188
doi: 10.1016/j.pbb.2015.03.008
Roiser JP, McLean A, Ogilvie AD, Blackwell AD, Bamber DJ, Goodyer I, et al. The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2005;30(4):775–85.
doi: 10.1038/sj.npp.1300659
Rana T, Behl T, Sehgal A, Singh S, Sharma N, Abdeen A, et al. Exploring the role of neuropeptides in depression and anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 2022;2(114): 110478.
doi: 10.1016/j.pnpbp.2021.110478
Park RJ, Scaife JC, Aziz TZ. Study protocol: using deep-brain stimulation, multimodal neuroimaging and neuroethics to understand and treat severe enduring anorexia nervosa. Front Psychiatry. 2018;9:24.
pubmed: 29681866
pmcid: 5898619
doi: 10.3389/fpsyt.2018.00024
Hay PJ, Touyz S, Sud R. Treatment for severe and enduring anorexia nervosa: a review. Aust N Z J Psychiatry. 2012;46(12):1136–44.
pubmed: 22696548
doi: 10.1177/0004867412450469
Lock J, Agras WS, Le Grange D, Couturier J, Safer D, Bryson SW. Do end of treatment assessments predict outcome at follow-up in eating disorders? Int J Eat Disord. 2013;46(8):771–8.
pubmed: 23946139
doi: 10.1002/eat.22175
Brietzke E, Mansur RB, Subramaniapillai M, Balanzá-Martínez V, Vinberg M, González-Pinto A, et al. Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments. Neurosci Biobehav Rev. 2018;94:11–6.
pubmed: 30075165
doi: 10.1016/j.neubiorev.2018.07.020
Kokkinou M, Ashok AH, Howes OD. The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Mol Psychiatry. 2018;23(1):59–69.
pubmed: 28972576
doi: 10.1038/mp.2017.190
Cheng B, Yang X, An L, Gao B, Liu X, Liu S. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson’s disease. Brain Res. 2009;25(1286):25–31.
doi: 10.1016/j.brainres.2009.06.060
Avraham Y, Bonne O, Berry EM. Behavioral and neurochemical alterations caused by diet restriction–the effect of tyrosine administration in mice. Brain Res. 1996;732(1–2):133–44.
pubmed: 8891277
doi: 10.1016/0006-8993(96)00514-8
Avraham Y, Hao S, Mendelson S, Berry EM. Hypothalamic-pituitary-adrenal responses to weight loss in mice following diet restriction, activity or separation stress: effects of tyrosine. Nutr Neurosci. 2002;5(5):327–35.
pubmed: 12385595
doi: 10.1080/1028415021000033794
Oberndorfer TA, Kaye WH, Simmons AN, Strigo IA, Matthews SC. Demand-specific alteration of medial prefrontal cortex response during an inhibition task in recovered anorexic women. Int J Eat Disord. 2011;44(1):1–8.
pubmed: 20127942
doi: 10.1002/eat.20750
Sato Y, Saito N, Utsumi A, Aizawa E, Shoji T, Izumiyama M, et al. Neural basis of impaired cognitive flexibility in patients with anorexia nervosa. PLoS ONE. 2013;8(5): e61108.
pubmed: 23675408
pmcid: 3651087
doi: 10.1371/journal.pone.0061108
Wierenga C, Bischoff-Grethe A, Melrose AJ, Grenesko-Stevens E, Irvine Z, Wagner A, et al. Altered BOLD response during inhibitory and error processing in adolescents with anorexia nervosa. PLoS ONE. 2014;9(3): e92017.
pubmed: 24651705
pmcid: 3961291
doi: 10.1371/journal.pone.0092017
Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav. 2008;94(1):121–35.
pubmed: 18164737
doi: 10.1016/j.physbeh.2007.11.037
Bajbouj M, Padberg F. A perfect match: noninvasive brain stimulation and psychotherapy. Eur Arch Psychiatry Clin Neurosci. 2014;264(Suppl 1):S27-33.
pubmed: 25253645
doi: 10.1007/s00406-014-0540-6
Elmasry J, Loo C, Martin D. A systematic review of transcranial electrical stimulation combined with cognitive training. Restor Neurol Neurosci. 2015;33(3):263–78.
pubmed: 25624425
Tsagaris KZ, Labar DR, Edwards DJ. A framework for combining rTMS with behavioral therapy. Front Syst Neurosci. 2016. https://doi.org/10.3389/fnsys.2016.00082 .
doi: 10.3389/fnsys.2016.00082
pubmed: 27895557
pmcid: 5108775
Martínez-Álvarez R. Radiosurgery for behavioral disorders. Prog Neurol Surg. 2019;34:289–97.
pubmed: 31096225
doi: 10.1159/000493076
Lipsman N, Woodside DB, Giacobbe P, Hamani C, Carter JC, Norwood SJ, et al. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet Lond Engl. 2013;381(9875):1361–70.
doi: 10.1016/S0140-6736(12)62188-6
Liu W, Li D, Sun F, Zhang X, Wang T, Zhan S, et al. Long-term follow-up study of MRI-guided bilateral anterior capsulotomy in patients with refractory anorexia nervosa. Neurosurgery. 2018;83(1):86–92.
pubmed: 28945886
doi: 10.1093/neuros/nyx366
Delvenne V, Goldman S, De Maertelaer V, Simon Y, Luxen A, Lotstra F. Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain. Biol Psychiatry. 1996;40(8):761–8.
pubmed: 8894069
doi: 10.1016/0006-3223(95)00522-6
Delvenne V, Goldman S, De Maertelaer V, Lotstra F. Brain glucose metabolism in eating disorders assessed by positron emission tomography. Int J Eat Disord. 1999;25(1):29–37.
pubmed: 9924650
doi: 10.1002/(SICI)1098-108X(199901)25:1<29::AID-EAT4>3.0.CO;2-#
Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008;13(8):663–81.
pubmed: 18704022
pmcid: 2729429
doi: 10.1017/S1092852900013754
Steele JD, Christmas D, Eljamel MS, Matthews K. Anterior cingulotomy for major depression: clinical outcome and relationship to lesion characteristics. Biol Psychiatry. 2008;63(7):670–7.
pubmed: 17916331
doi: 10.1016/j.biopsych.2007.07.019
Brown LT, Mikell CB, Youngerman BE, Zhang Y, McKhann GM, Sheth SA. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies. J Neurosurg. 2016;124(1):77–89.
pubmed: 26252455
doi: 10.3171/2015.1.JNS14681
Starzomska M, Rosińska P, Bielecki J. Chronic anorexia nervosa: Patient characteristics and treatment approaches. Psychiatr Pol. 2020;54(4):821–33.
pubmed: 33386730
doi: 10.12740/PP/OnlineFirst/118601
Schmidt U, Oldershaw A, Jichi F, Sternheim L, Startup H, McIntosh V, et al. Out-patient psychological therapies for adults with anorexia nervosa: randomised controlled trial. Br J Psychiatry J Ment Sci. 2012;201(5):392–9.
doi: 10.1192/bjp.bp.112.112078